Factors
Stocks
Valuation
Portfolio
Visualizations
More
Research date: July 10, 2026
Closing price before research date: $4.85
Current price: $4.64

Archer Aviation Inc. (NYSE: ACHR) — A Cheaper Seat on the Same Unproven Flight, Now Selling a Defense Story to Bridge the Cert Gap

Independent equity research note. Prepared 2026-07-10. As-of price $4.73 (2026-07-10 close).


⚡ Claude’s Take

This block is the author’s own independent opinion. It is general information, not investment advice. The analysis that follows (sections 1–15) takes no position and sets no price target — it is a straight, evidence-first assessment.

Verdict: AVOID at $4.73 / NOT-A-SHORT / accumulate only in the ~$2.50–3.50 zone (~$0.3–1.1B enterprise value). This is a venture-stage option — cheaper and later than Joby, wrapped in a fresh defense narrative — not an investable business. Archer is the clear #2 of the Western eVTOL race behind Joby: a credible, well-funded developer (~$1.8B liquidity, single-class governance, a Stellantis-built factory, a United anchor order) that is running roughly 6–12 months behind Joby on the only variable that matters — FAA type certification. Its flagship Midnight has closed FAA “Phase 3” and holds 100% Means-of-Compliance acceptance, but it is behind Joby’s Stage-5/TIA position, and credible handicappers put Archer’s actual type certificate in 2028 or later. To fill that visible gap, management has pivoted hard into a second story — an Anduril-partnered clean-sheet military VTOL and an “AI software / air-traffic” flywheel — that is genuine optionality but carries no program of record and no material revenue. FY2025 revenue was ~$0.3M; Q1-2026 was $1.6M, all of it airport-operations, none of it eVTOL. The company burned ~$538M of free cash flow in 2025 and now guides to a $170–200M quarterly adjusted-EBITDA loss — an accelerating burn it explicitly ties to spending ahead of defense awards it has not yet won.

The reason this is not a Joby-style “priced rich” call is that the market has already de-rated Archer ~70% from its October-2025 peak, to ~$1.9–2.0B enterprise value — roughly 40% of Joby’s ~$7B. You are paying far less for the same optionality. But cheaper is not cheap: at ~$1.9B EV you still pre-pay ~$1.9B for a second-place certification position, a mostly non-binding LOI order book, and a defense program that exists today as a press release and a prototype. The honest framing is a deflating moonshot / late-cycle capital-cycle option — factor-loaded as a pure high-beta speculative name (beta ~2.5, an 84% historical max drawdown, zero value/quality/momentum support, clustered with RKLB, Joby, Aurora, and nano-nuclear names). I would only underwrite the optionality where the price approximates net cash plus a modest option premium — roughly $2.50–3.50 (~$0.3–1.1B EV) — because a pre-revenue developer this far from certification, burning ~$700–800M a year, will dilute again, and the graveyard (Lilium, Volocopter) proves the left tail is zero. It is not a short: the balance sheet is a fortress, the defense narrative can re-rate the stock violently on any award, half the category is already dead so the survivor bid is real, and the borrow/squeeze risk on a retail-momentum name with out-of-the-money warrants is severe. Conviction: medium. Tag: “a cheaper seat on the same unproven flight.” Flips bullish if Archer wins a real Anduril-linked defense program of record (funded, named) or secures FAA type certification with demonstrated piloted unit economics. Flips bearish (toward a short) if certification slips past 2028 while a dilutive rescue raise prices below the prior round and the defense award fails to land — the Lilium failure mode, one rung lower on the cash ladder than Joby.


📈 Stock Price Action — Five-Year Event Map

Archer has round-tripped a speculative cycle twice and now sits near the bottom of the second. On the split/dividend-adjusted series, the all-time high is a $17.14 close (18-Feb-2021) — a pre-merger SPAC (Atlas Crest) euphoria print — and the all-time low $1.63 (27-Dec-2022). Within the operating era, the stock rebuilt to a 52-week high near $13.64 (adjusted close, 6-Oct-2025; ~$14.62 intraday 15-Oct-2025) before bleeding to a 52-week low of $4.68 (29-Jun-2026). It trades at $4.73 today — ~72% below the 2021 SPAC peak and ~65% below the October-2025 operating-era high. The price move in each row is a FACT; the attributed driver is INTERPRETATION.

# Period Approx. move Price (~from → to) Primary driver(s) Fact / Interp
1 Feb–Sep 2021 −48% $17.14 → $8.9 Atlas Crest SPAC deal (Feb-2021) + United order hype → pre-merger peak; Wisk/Boeing trade-secret suit (Apr-2021), valuation cut $2.7B→$1.7B EV; de-SPAC Sep-2021 Fact/Interp
2 Sep 2021–Dec 2022 −82% $8.9 → $1.63 ATL De-SPAC washout; rate shock crushes pre-revenue long-duration equity; dilution Fact/Interp
3 2023 +320% $1.63 → $6.9 Wisk/Boeing settlement (Aug-2023) + Boeing invests in ~$215M round; FAA special-airworthiness cert; Midnight build Fact/Interp
4 1H 2024 −55% $6.9 → $3.06 Dilutive raises, cash-burn drag, no certification catalyst; risk-off Fact/Interp
5 2H 2024 +270% $3.06 → $11.33 Piloted Midnight flights + FAA MoC progress; Anduril defense partnership + $430M raise (Dec-2024) Fact/Interp
6 Jan–Oct 2025 range → +26% $9–12 → $13.64 June-2025 eVTOL executive order/eIPP; first Abu Dhabi demo flight (Jul-2025); LA28 “official air taxi”; melt-up Fact/Interp
7 Nov 2025–Jul 2026 −65% $13.64 → $4.73 ~$1.8B FY25 equity raise/dilution; no type certificate; cert-timeline skepticism vs Joby; ARK selling; risk-off Fact/Interp

Cycle narrative. (1–2) The 2021–22 collapse is the archetypal de-SPAC story: a pre-revenue concept floated into a rising-rate market, compounded by the Wisk/Boeing trade-secret lawsuit that hung over the merger and forced a valuation cut. (3) The 2023 quadruple off the $1.63 low was catalyzed by removing that overhang — the August-2023 Wisk/Boeing settlement (Archer issued Wisk warrants and named it an autonomy provider; Boeing joined a ~$215M financing) plus the first FAA special-airworthiness certificate for Midnight. (4–5) 2024 was two halves: a dilution-driven drawdown to ~$3, then a near-quadruple into year-end as piloted flights, MoC acceptance, and — decisively — the December-2024 Anduril defense partnership and $430M raise re-rated the story from “air taxi” to “air taxi + defense.” (6) 2025’s grind higher to ~$13–14 tracked the June-2025 federal eVTOL executive order and eIPP, the first Abu Dhabi demonstration flight, and the LA28 designation — a narrative peak. (7) The ~65% decline since is mechanical and thematic at once: management monetized the spike with ~$1.8B of equity, the type certificate did not arrive, credible analysts began pricing Archer’s TC at 2028+, ARK Invest was a persistent seller, and the whole speculative complex de-rated. The stock now sits below where it traded before the 2025 melt-up — the market has fully given back the regulatory/defense premium while the company’s burn has accelerated. (Price history: AZI five-year CSV; drivers cross-referenced to 8-K filings, earnings dates, and the public news record.)


1. Executive Summary

Archer Aviation is a vertically integrated developer of electric vertical-takeoff-and-landing (eVTOL) aircraft, building toward an urban air-mobility (“air taxi”) business around its flagship Midnight — a piloted, four-passenger, twelve-rotor tilt-rotor aircraft (≈100-mile range, ≈150 mph, ≈45 dBA) designed for short, back-to-back 20–50-mile city hops. Founded in 2018 and public since a September-2021 SPAC merger with Atlas Crest Investment Corp., it is pre-commercial: it holds no FAA type certificate, operates no revenue-generating eVTOL service, and reported FY2025 revenue of roughly $0.3M and a Q1-2026 revenue of $1.6M — all of it from airport/flight operations (Hawthorne, LA), none from eVTOLs. FY2025 GAAP net loss was $618.2M; the underlying operating loss was $729.3M (the gap is a non-cash warrant/earnout fair-value gain booked as the stock fell — the mirror image of the loss inflation seen at peers whose stock rose).

The investment question is not “is this a good business” — it is not yet a business — but “is this a fairly priced option on becoming one, and how does it stack against Joby, the category leader we have already analyzed.” On both counts Archer reads as the cheaper, later #2. Cheaper: at ~$4.73 the equity is ~$3.6B, and net of ~$1.65B cash the enterprise value is only ~$1.9–2.0B — roughly 40% of Joby’s ~$7B — after a ~70% de-rating from the 2025 peak. Later: Archer has closed FAA “Phase 3” and holds 100% Means-of-Compliance acceptance, but it sits behind Joby’s Stage-5/Type-Inspection-Authorization position by an estimated 6–12 months, and independent handicappers place its actual type certificate in 2028 or beyond. Against that price a bull must underwrite the same stacked sequence as Joby — type certificate → production certificate → Part 135 operating certificate → proof that piloted air-taxi unit economics actually close — from one rung further back on the certification ladder.

What Archer has layered on top, and what distinguishes it from Joby, is a second story: defense. The December-2024 partnership with Anduril Industries to co-develop a clean-sheet, autonomous, hybrid-electric military VTOL — fed by acquired Overair/Karem tiltrotor IP and an in-house composites shop — is the most genuine differentiator in the thesis and the engine of the 2024–25 re-rating. It is also, as of mid-2026, optionality, not revenue: there is no program of record, and management folds all near-term defense into a combined $30–60M 2026 revenue token (UAE early ops + eIPP + defense). The company is spending ahead of these awards — guiding to a $170–200M quarterly adjusted-EBITDA loss — an accelerating ~$700–800M annual burn against ~$1.8B of liquidity, which implies a runway of roughly 2–2.5 years and a near-certainty of further dilution. Share count has already risen ~3.2x since the SPAC (to ~760M).

Archer’s genuine strengths are real but non-moat: a fortress balance sheet, a Stellantis-built factory (Covington, GA; exclusive contract manufacturing plus up to ~$400M of Stellantis labor/capex through 2030), a United Airlines anchor order (~200 aircraft, the only order with cash deposits down), an Abu Dhabi launch program, an LA28 Olympics halo, and — a clear governance positive — a single-class, one-share-one-vote structure after its founder super-voting shares auto-converted at year-end 2024. None of these is a durable Greenwald moat: there is no supply-side cost advantage, no customer captivity (airlines will multi-source; passengers have no switching costs), and no realized economies of scale, because there is no scale and no revenue to protect. For a fundamental investor Archer fails the screen on competitive advantage and on capital returns today — which does not make it a short (the balance sheet, the survivor dynamics, and the violent defense-award optionality argue otherwise), but does make it a speculative option that, even after a 70% fall, still embeds a stack of unproven outcomes.

2. Business Overview

What the company does. Archer designs, builds, certifies, and intends to operate an all-electric, piloted eVTOL aircraft — Midnight — optimized for short urban and airport-shuttle missions. The aircraft uses twelve propellers (six tilting on the leading edge plus six lift-only) in a lift-plus-cruise / partial-tilt architecture, carries one pilot plus four passengers, and is specified for roughly 100 miles of range at up to ~150 mph, with a payload above ~1,000 lb and a marketed acoustic signature near 45 dBA (management’s “~1,000× quieter than a helicopter”). It is designed for rapid back-to-back ~20-mile hops with short recharge intervals — a deliberate “first-principles” configuration Archer locked early and has held, in contrast to competitors that cycled through designs.

How it makes money — today versus the plan. Today, essentially not at all. FY2025 revenue was immaterial (~$0.3M); Q1-2026 revenue of $1.6M came from flight/airport operations at Hawthorne Airport (Los Angeles), which Archer took over and is modernizing into a mobility and R&D hub. There is no aircraft-sales revenue and no eVTOL passenger revenue yet. The planned model has three legs: (1) own-and-operate UAM air-taxi networks (Los Angeles, Abu Dhabi); (2) aircraft / “Launch Edition” sales to airline and operator partners abroad (UAE, India, Japan, Korea, Ethiopia); and (3) an emerging defense line — the Anduril-partnered autonomous hybrid VTOL, plus AI/air-traffic software adjacencies (Palantir, NVIDIA, Starlink relationships).

Segments and end-markets. There are no material reporting segments yet — Archer is effectively one R&D-plus-certification entity with a nascent airport-operations toehold. Target end-markets: urban/airport passenger shuttle (the core civil case), international launch markets (Gulf, South/East Asia, Africa), and defense/government (the newer, higher-optionality leg). Recurring revenue is, for now, moot: the only revenue is early operations income, and everything else is prospective.

Operating footprint. Headquarters in San Jose, CA; R&D and flight-test in California; manufacturing at the ARC facility in Covington, Georgia (~400,000 sq ft, certificate of occupancy December 2024, designed to expand to ~900,000 sq ft), built and operated with Stellantis as exclusive contract manufacturer, with a stated capacity target of 650 aircraft/year by 2030 (and a longer-term ambition above 2,000/year). Additional footprint includes a SoCal composites facility (acquired) and a UK (Bristol) engineering hub tied to the Anduril/defense effort. Verdict: Archer is a credible, well-capitalized development organization with a genuine head-start on physical manufacturing infrastructure and an unusually broad three-pronged strategy — but it is a pre-revenue developer whose only revenue today is airport operations, and whose civil, international, and defense legs are each unproven.

3. Industry Dynamics

Structure: a pre-revenue category in the destruction phase of a capital cycle. The eVTOL / Advanced Air Mobility (AAM) industry is, in 2026, one into which tens of billions of dollars flowed ahead of essentially any commercial revenue — the textbook setup the Marathon Capital Returns framework warns against: a compelling narrative (clean, quiet, on-demand urban air mobility) drew enormous capacity (dozens of funded aircraft programs) into a market with no proven unit economics and no current returns. The correction is well underway — Lilium (Germany) went insolvent in October 2024 and filed again in February 2025 after a rescue collapsed; Volocopter filed for insolvency in December 2024 — leaving a thinning field distinguished, for now, by balance-sheet depth and certification position rather than fundamentals.

Market size: the TAM is fiction; the near-term addressable market is a premium niche. Company and sell-side decks cite a ~$1T urban-air-mobility TAM — a top-down “share-of-all-urban-trips × assumed adoption” construct untethered from economics. The honest near-term market is helicopter substitution — airport shuttles, tourism, premium point-to-point hops, and defense/cargo — a high-end market measured in low single-digit billions, not trillions. The eVTOL does not create a new mass-transit category; it competes for a slice of an existing small, expensive one with a quieter and (eventually) cheaper product. Archer’s own CEO frames the civil prize as “a few dozen aircraft across the top 1,000 markets = >$100B of aircraft” — a large aircraft-sales number that still presupposes certification, scale, and closed unit economics.

Unit economics — the crux, and unproven. The economics only close if all four passenger seats fill on most flights, aircraft utilization is high, vertiport and charging infrastructure exists, and — decisively — the pilot is eventually removed via autonomy. With a pilot occupying one of five seats at aviation wages, the launch cost structure looks more like a helicopter charter than an Uber, and the “cheaper than a helicopter” claim presupposes a load factor no one has demonstrated. Archer is candid that scaling requires two additional unlocks beyond a certifiable design: industrial scale (auto-style volume manufacturing at cost) and airspace modernization (ATC capacity), both multi-year efforts partly outside its control.

Regulation — the binding constraint. US commercial operation requires three separate FAA approvals: a Type Certificate (the “powered-lift” special class), a Production Certificate (the factory), and a Part 135 Air Carrier Certificate (to operate for hire). No Western eVTOL holds a type certificate; only Chinese players (EHang, AutoFlight) have certified aircraft, in a different regulatory universe. The single live tailwind is the June-2025 federal executive order and the resulting eVTOL Integration Pilot Program (eIPP) (Federal Register, September 2025), which provides a structured pathway for early, pre-certification operations — a genuine accelerant that both Archer and Joby are confirmed to be participating in, but which does not substitute for the type certificate.

Value chain and barriers. Barriers to entry for new startups are now very high (capital, certification, time), which is why the field is consolidating rather than expanding — but that protects the surviving group, not any single firm. Barriers between the already-funded incumbents (Archer, Joby, Beta, Eve) are low: they build broadly similar aircraft into the same certification regime, with nil switching costs (no customers yet) and entirely prospective scale advantages. Suppliers (Honeywell, GE, batteries, avionics) are shared. Verdict: structurally unattractive today — a pre-revenue industry with unproven economics, heavy external-infrastructure dependence (vertiports, charging, ATC, pilots the OEM neither controls nor finances), severe regulatory gating, and an active capital-cycle bust. It could become attractive for one or two survivors if certification, vertiports, utilization, and eventually autonomy all land — but that is a stacked option, not a base case.

4. Competitive Position

The honest framing: Archer is the clear #2 of a race toward an unproven finish line — a later #2 than the price gap to Joby alone would suggest. Applying the Greenwald taxonomy explicitly — the three genuine advantages are supply-side cost advantage, demand-side customer captivity, and economies-of-scale-plus-captivity — Archer has none of them in durable form, because it has zero customers and zero scale. What it has are real relative positions, each pressure-tested below:

  • Certification position — behind Joby (the decisive fact). Archer is the first eVTOL to close the FAA’s “Phase 3” and holds 100% Means-of-Compliance acceptance — a real, industry-first milestone. But MoC acceptance is a prerequisite to Type Inspection Authorization, not TIA itself, and Joby entered Stage-5/TIA in March 2026 with a conforming aircraft flying and a multi-thousand-mile piloted test record. Independent trackers estimate Archer trails by 6–12 months, with credible skeptics placing Archer’s TC in 2028+. A certification lead is not a moat even for the leader — it is a perishable head start; being second in that race is a materially weaker position, because the leader certifies first, learns first, and (in Joby’s case) already owns scarce urban landing infrastructure and a helicopter-charter revenue base that Archer lacks.
  • Defense optionality (Anduril) — the genuine differentiator. This is the one dimension where Archer is arguably ahead of Joby: a clean-sheet, autonomous, hybrid-electric military VTOL co-developed with Anduril — a more aggressive, better-capitalized defense partner than Joby’s L3Harris — fed by acquired Overair/Karem tiltrotor IP and an in-house composites capability. It is a credible, differentiated bet. But it is optionality, not a moat and not yet revenue: no program of record, an aircraft not yet publicly shown, and “phased awards expected later 2026.” A defense program, if won, would be a genuine cash and validation event; until then it is a well-constructed call option.
  • Manufacturing partner (Stellantis). The most credible future cost-advantage candidate: Stellantis as exclusive contract manufacturer, contributing up to ~$400M of labor/capex through 2030 at the Covington plant. But it is prospective — no scale, no demonstrated unit-cost advantage — and Joby has its own automotive partner in Toyota (deeper-pocketed, ~$890M committed, manufacturing-system embedded). A cost advantage absent from the financials is a hypothesis.
  • Anchor customer and halo (United, LA28, Abu Dhabi). United’s ~200-aircraft order is the only one in the industry with cash deposits down ($10M), and the LA28 “official air taxi provider” designation is a marketing coup. But an airline order is not captivity — United can and will multi-source — and a sponsorship is not revenue.

Direct comparison. Against Joby, Archer is cheaper (~$2B vs ~$7B EV), later on certification, and lighter on real revenue (no Blade-equivalent), but broader on defense. Against Beta (well-funded, IPO’d late 2025, cargo/eCTOL-first), Eve (Embraer-backed, large conditional order book, later timeline), and EHang (certified but autonomous-tourism-only, in China), Archer is a well-funded, civil-passenger-focused Western #2 with a distinctive defense leg. Verdict: no durable competitive advantage. The “advantage” is a perishable, second-place certification position plus replicable partnerships and a genuine-but-unproven defense option. If a “moat” claim cannot be tied to a financial outcome that would deteriorate without it, it is not a moat — and here there is no financial outcome to protect.

5. Growth History and Forward Opportunities

History: R&D spend, not revenue. Archer has essentially no revenue history to speak of — the growth “history” is a spending and dilution history. Operating expense rose from ~$241M (2021) to ~$337M (2022), ~$445M (2023), ~$510M (2024), and ~$729M (2025); R&D specifically climbed from ~$64M (2021) to ~$494M (2025) as the company built Midnight, stood up the Covington factory, and — from late 2024 — opened the defense program. Revenue over the same span was effectively zero until the Q1-2026 Hawthorne toehold. This is a classic pre-commercial venture profile: cost and headcount scaled on the promise of a market, with the top line entirely prospective.

Forward opportunities — three legs, each a leap of faith. (1) US urban air mobility: requires an FAA type certificate, a production certificate, a Part 135 operating certificate, vertiport/charging infrastructure, and — critically — proof that per-flight economics close. The eIPP provides a pre-certification on-ramp (Archer selected across three winning applications spanning eight states; first flights targeted for later 2026), but eIPP operations are limited and not a substitute for certification. (2) International launch/aircraft sales: Abu Dhabi (transitioning Midnight onto a Restricted Type Certificate via the UAE GCAA for early “Launch Edition” commercial ops with Abu Dhabi Aviation), plus India (InterGlobe/IndiGo MOU, up to 200 aircraft), Japan (Soracle — JAL/Sumitomo — up to ~$500M/100 aircraft), Korea (Korean Air ~100), and Ethiopia. The overwhelming majority of these are non-binding LOIs/MOUs; only United carries deposits. (3) Defense: the highest-optionality leg — an Anduril-linked program that, if won, converts a press release into funded revenue.

What must go right. Certify Midnight (2027–2028 at the earliest), scale ARC to real volume at target cost, convert LOIs into firm deposits, launch profitable early operations in Abu Dhabi/LA, and land a defense program of record — all while absorbing a ~$170–200M quarterly adjusted-EBITDA loss and the dilution that funds it. Verdict: the growth is entirely forward and entirely unproven — high-potential but zero-quality in a fundamental sense, because none of it has yet produced a dollar of durable, repeatable revenue.

6. Financial Quality

Five-year financial snapshot ($M, FY ends 31-Dec; source: ROIC/EDGAR):

Metric FY2021 FY2022 FY2023 FY2024 FY2025
Revenue 0.0 0.0 0.0 0.1 0.3
R&D expense 64.3 171.5 276.4 357.7 493.9
SG&A expense 176.7 165.1 168.4 152.0 235.4
Operating loss (241.0) (336.6) (444.8) (509.7) (729.3)
GAAP net loss (347.8) (317.3) (457.9) (536.8) (618.2)
Stock-based comp 123.6 102.8 45.2 108.8 223.5
Operating cash flow (108.4) (200.4) (271.6) (368.6) (432.9)
CapEx (3.5) (6.9) (44.3) (82.0) (105.0)
Free cash flow (111.9) (207.3) (315.9) (450.6) (537.9)
Cash + ST investments (YE) 746.6 69.4 464.6 834.5 1,964.7
Wtd-avg shares (M) 110.8 240.5 270.4 376.7 624.3

The table tells the whole story at a glance: revenue flatlined at zero for five years while every cost line and the share count marched up, the operating loss tripled, and the cash balance is entirely a function of issuance (note the 2022 near-death dip to $69M before the 2023 recovery raises). The GAAP net loss being smaller than the operating loss in FY2025 (−$618M vs −$729M) is the warrant-gain artifact discussed below, not operating improvement.

Revenue: essentially zero. FY2025 revenue ~$0.3M; Q1-2026 ~$1.6M (airport operations). Any percentage or multiple built on this base (the P/S of ~1,900× is arithmetic noise) is meaningless. This is a cost-and-cash story, not an earnings story.

Losses and the GAAP-vs-underlying gap (the quality-of-earnings tell). FY2025 operating loss was −$729.3M; GAAP net loss was −$618.2M. The ~$111M gap is non-operating income — primarily a non-cash mark-to-market gain on warrant/earnout liabilities as the stock declined in 2025, plus interest income on the cash pile. This is the mirror image of the dynamic at peers whose stock rose (inflating GAAP losses): here, a falling share price flattered the GAAP net loss. Use the operating loss (−$729.3M), not the GAAP net loss, as the run-rate. The multi-year operating-loss trajectory is unambiguous: −$241M (2021) → −$337M → −$445M → −$510M → −$729M (2025) — losses widening as spending scaled, now accelerating into the defense push.

Stock-based compensation — large and growing. SBC was $223.5M in FY2025 (up from $108.8M in FY2024 and $45.2M in FY2023) — roughly 31% of operating expense. This is a material, recurring, non-cash cost that both understates the true economic burn in any “adjusted” figure and is a direct driver of dilution. Management’s guided adjusted-EBITDA loss of $170–200M for Q2-2026 excludes SBC and other items; the all-in cash-plus-dilution burn is meaningfully larger.

Cash burn — accelerating. Operating cash flow was −$432.9M in FY2025 (−$200M/−$272M/−$369M in 2022–24), and with ~$105M of capex, free cash flow was −$537.9M. The Q2-2026 adjusted-EBITDA-loss guide of $170–200M annualizes to roughly $700–800M, and management explicitly flags elevated spend on the defense platform and the Midnight production ramp. This is a business whose cash consumption is rising, not falling, as it approaches (but has not reached) commercialization.

Balance sheet — the genuine strength. At 31-March-2026, cash and short-term investments were $1,775.9M against total debt of only ~$122M (largely finance leases plus ~$79M borrowings; management describes it as “<$100M, clean, flexible”), for net cash of ~$1.65B. Shareholders’ equity was ~$2.08B against an accumulated deficit of ~$2.52B; the current ratio is ~18×. Book value per share is ~$2.71, so at $4.73 the stock trades at ~1.8× book (32nd percentile of its own history — notably cheaper than Joby’s ~4.3×). Runway on the current ~$700–800M burn is roughly 2–2.5 years, which — given the burn is rising and management raises opportunistically into strength — makes another equity raise a near-certainty well before first material revenue.

ROIC/ROE — not meaningful. With no operating profit, returns on capital are deeply negative and uninformative; the relevant capital metric is burn per unit of certification progress, and on that measure Archer is spending ~$700–800M/year to close a certification gap to a better-funded leader. Verdict: economics do not yet exist — there is no scale at which they “improve,” because there is no revenue. The balance sheet buys time; it does not close the fundamental question, which is whether piloted eVTOL (and now hybrid-defense) unit economics can ever be made to work. On quality-of-earnings, the key catch is that the smaller GAAP net loss is a warrant-driven artifact of a falling stock, not operational improvement.

7. Capital Allocation

Management as financier, not yet steward. Archer’s capital-allocation record is, by the nature of a pre-revenue developer, a fund-raising record rather than a returns record — and on fund-raising, management has been skilled, opportunistic, and relentless. The company funds its entire burn with equity (there is no large convertible-note program, unlike Joby’s ~$690M convert). Equity issuance recorded in the cash-flow statement traces the ladder — ~$600M (2021 SPAC/PIPE era), ~$0 (2022), ~$261M (2023), ~$783M (2024), and ~$1,858M (2025) — with cumulative cash sourced since the SPAC comfortably above ~$2.5–2.6B (and closer to ~$3B including Stellantis’s in-kind equity). Landmark discrete events: the September-2021 SPAC + PIPE (~$857.6M gross, Atlas Crest); the December-2024 Anduril-linked PIPE — 63.9M shares at $6.65 = ~$425M gross, explicitly earmarked for the joint defense-aircraft development; the June-2025 registered direct85.0M shares at $10.00 = $850M gross, timed to the White House eVTOL executive order (the marquee “raise-into-strength” move, though the stock fell ~15% on the print); three ~$70M ATM programs (~$204M total); and the Stellantis Forward Purchase Agreement cash draws (49.3M shares/~$158M in 2024, plus smaller tranches). The cost of capital was punishing — the bulk sold at $3.25–$6.65, only the $850M June-2025 tranche at $10. The result: share count up ~3.2×, from ~240M post-SPAC to 759.6M (May-2026). This trajectory guarantees further dilution before first material revenue.

Governance — a real positive versus peers. Unlike many founder-controlled story stocks (and unlike its own 2021 self), Archer is now single-class, one-share-one-vote: the Class B super-voting (10-vote) founder shares auto-converted 1:1 to Class A effective 31-December-2024 per the charter, and no further Class B will be issued. CEO Adam Goldstein holds ~37.0M shares = ~4.9% economic and voting — he does not control the company (a materially better structure than Joby’s entrenched-founder economics). Co-founder Brett Adcock departed early (later founding Figure AI). Top holders: Stellantis ~10.1% (78.2M shares; now below the 12.5% board-nomination threshold), BlackRock ~7.0%, Goldstein ~4.9%. A 2026 proxy item proposes reincorporation from Delaware to Texas. The SPAC-era $11.50 warrants (ACHR WS) remain outstanding — out-of-the-money at $4.73, dilutive only above $11.50. One flag: Goldstein owns >10% of and sits on the board of Neon Aero Inc., a related party as of August-2025 (~$0.6M payable at year-end) — worth monitoring.

The Stellantis machinery — edge and dilution vehicle. Two arrangements sit behind the factory: an exclusive contract-manufacturing agreement (FCA US builds Midnight at Covington) and a labor-and-capital-for-equity structure (Stellantis contributes manufacturing labor/capex and takes Archer stock, booked partly as warrant/R&D expense), up to ~$400M through 2030. This is genuinely a cheaper route to manufacturing scale than building a plant from cash — but it is simultaneously a permanent-dilution vehicle, converting a capex/opex line into share issuance. Real edge, real cost.

M&A — small and technology-driven. Bolt-on, capability-oriented deals rather than empire-building: the Overair (Karem-derived) tiltrotor patent portfolio and talent and a ~60,000 sq ft composites facility to feed the defense program. Goodwill is negligible (~$0.1–2.4M), consistent with asset/team tucks. No buybacks or dividends (and none appropriate pre-revenue).

Insider behavior — a modest positive versus Joby, but recent tape is distribution. A direct scan of the Form 4 record surfaces a real — if small — vote of confidence that Joby’s record entirely lacks: a January-2023 open-market buy-cluster at the sub-$3 lows — CEO Goldstein (39,526 sh @ $2.54), CFO Mark Mesler (20,000 @ $2.63), and directors Michael Spellacy (23,116 @ $2.60) and Fred Diaz (19,322 @ $2.59), ~$0.26M combined — plus small director buys by Deborah Diaz ($4.47 in 2023, $7.48 in 2024). (Note: a preliminary reading of a large November-2024 Goldstein filing as a ~$15M purchase does not survive verification — those ~3.0M shares at $4.63–5.15 were sales; his open-market buy that month was a token 19,762 shares/~$101K.) So the honest read is: a handful of genuine, small purchases concentrated at the 2023 lows — better than Joby’s zero, but not large-scale conviction — followed by one-directional distribution through the 2025–26 cycle (routine option-exercise/grant/sale flow, an FY2026 wave of ~22 Form 144 proposed-sale notices, and the CEO a net ~$15M seller in Nov-2024). Marquee smart money is leaving: ARK Invest, after buying ~$26M in Nov-2025, dumped ~4.3M shares (incl. ~$12.7M on 8-June-2026) into certification-delay worries.

Incentives — the Joby pattern, confirmed. CEO Goldstein’s FY2025 total comp was ~$11.4M (mostly stock; cash bonus paid at 150% of target). Critically, incentive metrics key entirely off operational milestones (FAA certification progress; flight-test hurdles — “flights over 50 miles, >30 min, >10,000 ft, >150 mph”; manufacturing scale-up) and Relative TSR vs. the S&P 600 for long-term PSUs — with a legacy 20.0M-PSU “Founder Grant” vesting on stock-price hurdles. There is no ROIC, EPS, revenue, FCF, or dilution/share-count accountability anywhere. Management is paid to hit engineering milestones and move the stock — not to allocate capital efficiently or limit dilution. Verdict: a capable, opportunistic financier operating with genuinely clean single-class governance and disciplined, capability-focused M&A — but a team spending ahead of unwon awards, funding an accelerating burn with serial dilution, incentivized without any capital-efficiency metric, watching its smart-money holders exit, and not yet tested as a steward of returns.

8. Changes and Headwinds — Last Two Years

Strategic changes (mostly additive narrative). The defining change is the December-2024 Anduril defense partnership and the pivot to a “multi-platform” (civil + defense + AI-software) strategy — the engine of the 2024–25 re-rating. Around it: the Palantir partnership (March 2025; Foundry/AIP for manufacturing and an AI/air-traffic angle, with Palantir a finalist in the FAA’s SMART program), NVIDIA and Starlink technology relationships, the Overair IP and composites-facility acquisitions, the Anduril/EDGE (UAE) “Omen” powertrain deal (November 2025), and a UK (Bristol) engineering hub. On the civil side: first Abu Dhabi demonstration flight (July 2025) and the transition toward a UAE Restricted Type Certificate for early ops; the LA28 “official air taxi provider” designation; the Hawthorne Airport takeover (first operations revenue); and continued Midnight flight-test expansion (two aircraft flying, fleet of 8–10 being built, 50-aircraft/year capacity targeted).

Certification progress — real but still short of the finish. Archer closed FAA “Phase 3,” reached 100% MoC acceptance, and moved into for-credit work — genuine milestones — but remains behind Joby’s TIA position and without a type certificate.

Headwinds. (1) Certification skepticism — credible analysts pushing Archer’s TC to 2028+, undercutting the 2026–27 commercialization narrative. (2) Accelerating burn and dilution — the $170–200M quarterly loss guide and the ~$1.8B of 2025 issuance. (3) The capital-cycle bust — Lilium and Volocopter insolvencies as a live reminder of the left tail. (4) Persistent insider/ARK selling and a ~70% price de-rating that has raised the cost of future capital. (5) Execution dependency on parties Archer does not control — the FAA, vertiport developers, ATC modernization, and the Anduril program timeline. Verdict: the last two years added narrative (defense, international, software) and cash, but did not de-risk the core thesis — the type certificate has not arrived, the burn has risen, and the stock has given back the entire 2025 premium.

9. Risk Analysis (Risk Matrix)

Risk Likelihood Impact Evidence / Basis
Certification slips (TC past 2027–28) High High Behind Joby’s TIA; analysts model Archer TC 2028+; no Western eVTOL certified; industry-wide slippage history
Further dilution below prior rounds High Med-High ~$700–800M annual burn vs ~$1.8B cash; ~3.2× share growth since SPAC; ~$1.86B issued in 2025 alone
Unit economics never close Med-High High Pilot cost, load factor, vertiport/ATC dependence; no eVTOL operator has proven piloted economics at scale
Defense program not won / delayed Med-High Med-High No program of record; spending ahead of awards; “phased awards” only “expected later 2026”
Capital-cycle failure (Lilium mode) Low-Med Very High Lilium/Volocopter insolvent; left tail is zero; mitigated near-term by ~$1.65B net cash and survivor bid
Competitive leapfrog (Joby/Beta/China) Med Med-High Joby ahead on cert + owns Blade slots; Beta well-funded; EHang certified in China; low inter-incumbent barriers
Key-person / execution Med Med Founder-driven; broad three-front strategy strains focus and capital; Adcock (co-founder) already departed
Infrastructure/ATC dependency High Med Vertiports, charging, ATC modernization outside Archer’s control; multi-year, public-private
Warrant/earnout FV volatility (optics) High Low Non-cash GAAP swings obscure the run-rate; a reporting-clarity risk, not an economic one
Regulatory/geopolitical (UAE, export) Med Med UAE GCAA track separate from FAA; defense export controls; reliance on foreign launch markets

Catastrophic-loss risk is real but not the base case: a certification failure or a failed rescue raise into a closed market is the Lilium/Volocopter path to ~zero, but Archer’s ~$1.65B net cash, single-class governance, and the violent optionality of a defense award make a total loss a tail rather than a central scenario over the next 2–3 years.

10. Valuation Discussion (Embedded Expectations)

Multiples are meaningless; this is a sum-of-the-parts option. With ~$0.3M of revenue and deep operating losses, every conventional multiple (P/E, EV/EBITDA, P/S) is either negative or arithmetic noise. The only coherent way to value Archer is as net cash plus an option on the eVTOL/defense franchise:

  • Live enterprise value: ~$4.73 × ~760M shares ≈ ~$3.6B market cap; less ~$1.65B net cash ≈ ~$1.9–2.0B enterprise value. That ~$1.9B is the residual the market pays for the eVTOL program, the international/Launch-Edition pipeline, the defense option, and the software adjacency — combined.
  • Peer anchor: Joby trades at ~$7.0B EV for a leading certification position, a deeper balance sheet, scarce Blade landing slots, and real (if low-margin) charter revenue. Archer at ~$1.9B EV is ~40% of Joby’s option value — a discount that is warranted (later cert, no revenue base) but is not obviously too large, which is precisely why this is an AVOID rather than a short.
  • Own-history valuation context: the stock trades at ~1.8× book (32nd percentile of its own range) — cheaper than Joby (~4.3×, mid-range) and far below its own SPAC-era and 2025 peaks. Book value (~$2.71/share) is largely the cash pile, so P/B here is closer to a price-to-net-cash-plus-PP&E read than a franchise multiple.

Embedded-expectations analysis — what must be true at ~$1.9B EV? The market is underwriting, at a probability-weighted level, that Archer certifies Midnight, scales manufacturing at acceptable cost, converts a meaningful slice of its LOI book into deliveries, and/or wins a defense program — i.e., that the ~$1.9B option finishes in the money. What the market is (correctly) not paying for is any near-term profit: the ~$30–60M 2026 revenue token is trivial, and consensus does not model positive free cash flow for years. Scenario sketch:

  • Bear (~$0.3–1.1B EV): certification slips to 2028+, a defense award fails to land, and a dilutive rescue raise prices below the prior round; the stock converges toward net cash plus a small option stub — roughly the $2.50–3.50 zone. The Lilium tail (toward zero) is low-probability but non-zero, cushioned by ~$1.65B net cash.
  • Base (~today, high-variance dead money): Archer grinds through eIPP and Abu Dhabi early ops, keeps burning and diluting, and the type certificate stays 1–2+ years out; the stock chops in a wide band around ~$1.5–3B EV, its direction set by cert headlines and the defense timeline rather than fundamentals.
  • Bull (~$4–8B+ EV): a funded Anduril-linked defense program of record lands and/or Midnight secures type certification with credible unit economics; the stock re-rates violently toward — and potentially through — its 2025 highs, closing much of the gap to Joby.

Scenario summary (enterprise value; the option is dominated by two binaries — certification and a defense award):

Scenario Certification Defense (Anduril) Dilution Implied EV Rough price*
Bear Slips to 2028+ No funded award Below-prior-round rescue raise ~$0.3–1.1B ~$2.50–3.50
Base 1–2+ yrs out, grinding Optionality persists Recurring, at-market ~$1.5–3.0B ~$4–6
Bull TC 2027 w/ real economics Funded program of record Manageable ~$4–8B+ ~$9–15+

*Illustrative, on ~760M shares plus ~$1.65B net cash; not a price target — a sensitivity to show where the binaries lead. The bear converges toward net-cash-plus-stub; the bull closes the gap to Joby’s ~$7B and revisits the 2025 highs.

No price target; no recommendation here (the single directional view lives only in the author’s opening take, above). The valuation verdict: Archer is not expensive on any franchise metric — it is unpriceable on fundamentals and only sensibly framed as a cheap-ish option whose value is dominated by two binary, largely exogenous events (certification and a defense award), funded by a burn that guarantees further dilution.

11. Variant Perception

Consensus belief. The bullish consensus holds that Archer is a well-funded, front-of-pack Western eVTOL developer with a unique second engine — the Anduril defense program — that de-risks the story versus a pure air-taxi bet, and that the ~70% de-rating has created an attractive entry into optionality that will re-rate on certification and defense catalysts. The bearish consensus holds that it is a cash-burning, pre-revenue moonshot that is behind the leader on the only metric that matters, with a mostly non-binding order book and an accelerating burn.

Strongest bull case. Half the category is already dead, leaving Archer one of two or three funded Western survivors; it has a fortress balance sheet, clean single-class governance, a real factory with Stellantis, the only order with cash down (United), and — uniquely — a credible defense partner in Anduril attacking a multi-billion-dollar DoD program. If either binary lands (a funded defense award or type certification with real economics), a ~$1.9B EV is far too low, and the stock re-rates toward Joby’s ~$7B — a >2–3× move.

Strongest bear case. Archer is a later, revenue-lighter Joby burning more cash (relative to progress) to close a certification gap it may not close before 2028, spending ahead of defense awards it has not won, and funding it all with serial dilution (~3.2× shares since SPAC; ~$1.86B issued in 2025). The order book is mostly LOIs; the “revenue” is a $30–60M token; and the left tail — a Lilium-style failed rescue — is real. Cheaper than Joby is not the same as cheap.

The 3–5 assumptions that matter most: (1) Certification timing — 2027 vs 2028+ is the whole game; (2) Defense conversion — does the Anduril program become a funded award, and when; (3) Dilution — how much, and at what price, before first material revenue; (4) Unit economics — can piloted eVTOL (and hybrid-defense) economics be made to work at scale; (5) Survivor dynamics — does capital keep flowing to the survivors, or does risk-off starve the burn.

The factor-positioning read (evidence, not a call). The tape and the factor model corroborate the “deflating moonshot” framing: beta ~2.5, an 84% five-year maximum drawdown, a −67%/−72% de-rating off the peak, and factor loadings that are pure speculation — a large “Space & Quantum Innovators” (moonshot) loading and strong negative Liquidity/Low-Volatility loadings, with zero surviving Value, Quality, Momentum, Growth, or Size style exposure (idiosyncratic vol ~50% annualized; R² ~0.39). Its factor-nearest neighbors are Rocket Lab, Joby, Aurora (autonomous trucking), and nano-nuclear names — the speculative-narrative complex, not any fundamental cohort. This says consensus is not treating Archer as a value or quality name; it is a high-beta option on a narrative, which cuts both ways — brutal on the way down (as realized), explosive on any genuine de-risking catalyst. Where consensus may be offsides: the market has priced Archer down to a level that already discounts a lot of bad news, so the asymmetry from here is less “short a bubble” than “cheap-ish option with two live binaries” — which is exactly why the discipline is avoid-and-wait, not short.

12. Fact vs. Interpretation

# Statement Type Basis
1 FY2025 revenue ~$0.3M; Q1-2026 ~$1.6M (airport ops, not eVTOL) Fact Archer 8-Ks / earnings releases
2 FY2025 operating loss −$729.3M; GAAP net loss −$618.2M Fact ROIC/EDGAR; 10-K
3 The ~$111M net-vs-operating gap is a non-cash warrant/earnout FV gain (stock fell) Interpretation Standard eVTOL warrant accounting; sign consistent with price decline
4 Net cash ~$1.65B at 31-Mar-2026 (cash+STI $1,775.9M less ~$122M debt) Fact 10-Q balance sheet
5 Live EV ~$1.9–2.0B; ~40% of Joby’s ~$7.0B Interpretation Price × shares less net cash; peer comparison
6 Archer is ~6–12 months behind Joby on certification Interpretation Third-party cert trackers; Joby in TIA, Archer in for-credit phase
7 Anduril defense program has no program of record / no material revenue yet Fact Management commentary; “phased awards expected later 2026”
8 Order book is majority non-binding LOIs/MOUs; only United carries deposits Fact 8-Ks; deal disclosures
9 Dual-class founder control ended 31-Dec-2024 (Class B auto-converted); now one-share-one-vote Fact DEF 14A 2026 / charter
10 ~$700–800M annual burn implies further dilution within ~2–2.5 years Interpretation Q2-26 guide annualized vs cash balance
11 A funded defense award or type certification would re-rate the stock materially Interpretation Option framing; peer EV gap

13. Open Questions

  1. Certification date: what is the realistic FAA type-certificate timeline for Midnight — 2027, 2028, or later — and how does Archer’s for-credit progress compare, milestone-for-milestone, with Joby’s TIA?
  2. Defense economics: what is the size, funding, and timing of the Anduril-linked program, and is there a named DoD (or UK) program of record Archer is competing for?
  3. Unit economics: what are the actual per-flight economics at Hawthorne and (prospectively) Abu Dhabi — load factor, utilization, cost per flight — and do they pencil at scale?
  4. Dilution path: how much additional capital is required to reach first material revenue, and at what price would the next raise likely come?
  5. LOI conversion: what share of the “billions” order book (India, Japan, Korea, Ethiopia) will convert into firm, deposit-backed orders, and on what timeline?
  6. Insider conviction: has any officer or director made an open-market purchase, ever — and are executive incentives tied to anything other than operational milestones?

14. What Must Be True

Bull case — what must be true: Archer must (a) achieve FAA type certification for Midnight on a credible timeline (2027–2028), (b) scale ARC manufacturing with Stellantis at a cost structure that makes eVTOL economics work, © convert a meaningful portion of its LOI book into deliveries and/or win a funded Anduril-linked defense program of record, and (d) do so without a value-destroying, below-prior-round dilution. Falsification test: if, by end-2027, Archer has not entered TIA-equivalent for-credit flight testing with the FAA and has not won or been down-selected for a funded defense program, the bull thesis is broken — the company will be a later-still #2 burning toward another dilutive raise.

Bear case — what must be true: the bear must be right that (a) certification slips materially (2028+), (b) the defense program stays optionality rather than funded revenue, and © the burn forces dilution that compresses per-share value faster than milestones add it. Falsification test: if Archer wins a named, funded defense program of record or reaches FAA type certification with demonstrated piloted unit economics, the bear thesis is broken and the ~$1.9B EV is revealed as far too low.


The Source Appendix follows as Appendix B in the combined report.


APPENDIX A — Standard Diligence Questionnaire

Archer Aviation Inc. (NYSE: ACHR) — as of 2026-07-10

Supplemental to the research memo. Fact / Interpretation / Assumption labeled where it matters. Where a question does not map to a pre-revenue developer, the correct analog is given.

General

What thoughtful questions have other investors asked? The recurring, high-signal questions are: (1) When does Midnight actually get an FAA type certificate — 2027, 2028, or later — and how far behind Joby is Archer? (2) Is the Anduril defense program real revenue or a narrative? (3) How much more dilution before first material revenue? (4) Do piloted eVTOL unit economics ever close? (5) How much of the “billions” order book is binding? These map directly to the memo’s Open Questions and What-Must-Be-True.

Cyclicality & Earnings Nature

  • Cyclical high or low? Neither — there are no earnings. Losses are widening structurally (−$729M operating loss FY2025) as spending scales; this is a venture-stage cost curve, not a cycle. (Fact)
  • Driven by external environment or internal action? Internal (R&D, factory build, defense program), amplified by an external regulatory tailwind (June-2025 eVTOL EO / eIPP) and an external capital-cycle bust (Lilium/Volocopter insolvencies). (Interpretation)
  • Revenue stability? No revenue base to speak of (~$0.3M FY2025; $1.6M Q1-2026, airport operations). (Fact)
  • Product/service outlook; market size? The addressable near-term market is premium helicopter-replacement (low-single-digit-$B), not the ~$1T UAM TAM decks cite; management frames a >$100B aircraft-sales opportunity across the top 1,000 markets, contingent on certification and scale. Growing in potential, non-existent in realization. (Interpretation)

Business Quality & Competitive Moat

  • Industry more or less competitive? Consolidating (Lilium/Volocopter dead), so fewer players — but barriers between funded incumbents (Archer, Joby, Beta, Eve) are low; no firm-specific moat results. (Interpretation)
  • How profitable is the business (ROIC/ROE)? Deeply negative and not meaningful — no operating profit. The relevant metric is burn per unit of certification progress. (Fact)
  • How profitable is the industry; barriers? Industry profit pool today is ~zero; barriers to new entry are high (capital, certification), but that protects the surviving group, not Archer specifically. (Interpretation)
  • Easily understood? The concept is simple; the value driver (binary FAA certification + a binary defense award, funded by dilution) is a venture option, not a stable business. (Interpretation)
  • Undermined by foreign low-cost labor? Not labor — but Chinese eVTOL (EHang certified; long-run export cost threat) is a real 2030s risk. (Interpretation)
  • Do brands matter? Switching costs? Passenger brand is prospective; airline customers will multi-source; switching costs are nil (no customers yet). No captivity. (Interpretation)

Financial Condition & Balance Sheet

  • Unrecognized assets / off-balance-sheet liabilities? The Stellantis manufacturing labor/capex commitment (up to ~$400M through 2030) and the value of acquired Overair/Karem IP are strategic assets not fully reflected in book value; the SPAC $11.50 warrants and SBC overhang are dilution liabilities. (Interpretation)
  • Accounting conservatism? GAAP net loss (−$618.2M) is smaller than the operating loss (−$729.3M) because of a non-cash warrant/earnout FV gain as the stock fell — an optics artifact; the operating loss is the honest run-rate. Otherwise accounting is standard. (Interpretation)
  • CapEx-hungry? Yes — factory build-out and flight-test fleet; ~$105M capex FY2025, rising with the production ramp. (Fact)

Capital Allocation & Management

  • FCF generation / use? Deeply negative FCF (−$537.9M FY2025); “capital allocation” is fund-raising, not returns. (Fact)
  • Acquisitions? Small, capability-focused (Overair patents/talent; a composites facility) to feed the defense program; goodwill negligible. (Fact)
  • Buybacks? None (and none appropriate). (Fact)
  • Issuing shares to insiders / dilution? Heavy dilution — ~3.2× shares since the SPAC (~240M → 759.6M); ~$1.86B of equity issuance recorded in 2025 (headlined by an $850M June registered direct at $10). SBC $223.5M FY2025 (~31% of opex). Insider Form 4 record (verified): a small but genuine open-market buy-cluster at the Jan-2023 sub-$3 lows (CEO Goldstein, CFO Mesler, two directors, ~$0.26M) — better than Joby’s zero — but 2025–26 is one-way distribution (Form 144 wave; CEO a net ~$15M seller Nov-2024) and ARK Invest is exiting. No large-scale conviction buying. (Fact)
  • Comp / motivations? CEO Adam Goldstein FY2025 comp ~$11.4M (mostly stock; cash bonus at 150% of target); no board fees. Incentives key only off operational milestones (certification, flight-test hurdles) and relative TSR — no ROIC/EPS/revenue/FCF/dilution accountability. Governance positive: founder super-voting Class B auto-converted to one-share-one-vote on 31-Dec-2024 (Goldstein ~4.9%, insiders ~5.3% of vote). Related-party flag: Goldstein board/>10% owner of Neon Aero. A 2026 proxy item proposes Delaware→Texas reincorporation. (Fact)

Valuation & Market Data

  • ADR / MLP / K-1? No — US-domiciled (Delaware; proposed Texas) common stock, single class (Class A), plus listed $11.50 warrants (ACHR WS). Not an ADR/MLP/K-1. (Fact)
  • Dividend? None. (Fact)
  • Net income vs cash from operations? Both deeply negative; GAAP net loss is flattered relative to operating loss by non-cash warrant gains, while operating cash burn (−$432.9M) is the cleaner drain. (Fact)
  • Valuation frame: unpriceable on multiples; only sensible as net cash (~$1.65B) plus a ~$1.9–2.0B option — ~40% of Joby’s ~$7B EV; ~1.8× book (32nd percentile own-history). (Interpretation)

Risks & Downside

  • What would cause the stock to decline? Certification slippage (2028+), a failed/absent defense award, a dilutive below-prior-round raise, a risk-off flight from speculative names, or a Lilium-style rescue failure. (Interpretation)
  • Catastrophic / total-loss risk? Real but not base-case: a certification failure or failed rescue into a closed market is the path toward ~zero (cf Lilium/Volocopter), cushioned near-term by ~$1.65B net cash and the survivor bid. (Interpretation)

Recent News & Events

  • Environment changed recently? Yes — the defense pivot (Anduril, Dec-2024), the June-2025 eVTOL EO / eIPP, first Abu Dhabi flight (Jul-2025), LA28 designation, Hawthorne operations, and closing FAA “Phase 3.” But no type certificate and an accelerating burn (Q2-26 adjusted-EBITDA-loss guide $170–200M). (Fact)
  • Accounting policy changes? None material beyond ordinary warrant/earnout remeasurement. (Fact)
  • New markets/facilities/management? New: ARC Covington factory occupancy (Dec-2024), SoCal composites facility, UK Bristol defense hub, Hawthorne Airport operations; co-founder Brett Adcock departed early (founded Figure AI). (Fact)

APPENDIX B — Source Appendix

Archer Aviation Inc. (NYSE: ACHR) — as of 2026-07-10

Primary sources first. Internal/Drive context labeled. Third-party aggregated data reconciled to filings where material.

Primary — SEC filings (EDGAR, CIK 0001824502; corpus mirrored locally to output/ACHR/sources/)

  • Form 10-Q, Q1-2026 (filed 2026-05-11, period ended 2026-03-31) — balance sheet (cash+STI $1,775.9M; debt ~$122M; equity $2,079.4M; accumulated deficit $2,521.5M); cover: 759,598,009 Class A shares outstanding as of 2026-05-06. https://www.sec.gov/Archives/edgar/data/1824502/000182450226000038/achr-20260331.htm
  • Form 10-K, FY2025 and FY2021–FY2024 annuals — income statement (FY2025 operating loss −$729.3M; net loss −$618.2M; revenue ~$0.3M; SBC $223.5M; R&D $493.9M), cash flow (OCF −$432.9M; capex −$105M; FCF −$537.9M; equity issuance $1,858.1M). (output/ACHR/sources/10-K/)
  • Form 8-K, Q1-2026 results (2026-05-11) and Q4/FY2025 results (2026-03-03) — revenue, liquidity, Q2-2026 adjusted-EBITDA-loss guide $170–200M. (output/ACHR/sources/8-K/)
  • Form 8-K, 2026-05-14 / 2026-06-30 — recent corporate events / financing. (output/ACHR/sources/8-K/)
  • DEF 14A (2026-04-30) — single-class (one-share-one-vote) confirmation: Class B auto-converted to Class A effective 2024-12-31; directors/officers ~5.3% of voting power; proposed Delaware→Texas reincorporation; CEO Goldstein compensation. https://www.sec.gov/Archives/edgar/data/1824502/ (DEF_14A/2026-04-30)
  • DEF 14A (2022-04-29) — historical dual-class (Class B = 10 votes); insiders ~78% of voting power in 2022; board (Adcock, Goldstein, Munoz, Pilarski, Pinelli). (output/ACHR/sources/DEF_14A/)
  • Form 4 / Form 144 corpus (2021–2026) — insider transactions; wave of Form 144 proposed-sale notices May–June 2026. (EDGAR; enumerated via scripts/edgar.sh)
  • Form 425 / S-4 (2021) — Atlas Crest SPAC merger materials. (output/ACHR/sources/425/, S-4-A/)

Primary — company IR, earnings call

  • Archer Q1-2026 earnings call transcript (2026-05-11) — via ROIC.ai; management (Goldstein, CFO Priya Gupta, Tom Muniz [defense], Benjamin Lyon [Midnight cert]) on FAA 4-phase framing (closed Phase 3), multi-platform civil/defense/AI strategy, Anduril clean-sheet hybrid, UAE Restricted Type Certificate / Launch Edition, Hawthorne operations, $1.8B liquidity, Q2 burn guide.
  • investors.archer.com / archer.com/news — Midnight specs, ARC Covington facility, partnership announcements.

Third-party quantitative (aggregated; reconciled to filings)

  • ROIC.ai MCP (accessed 2026-07-10) — income statement, balance sheet, cash flow, enterprise value, profitability/valuation multiples (FY2021–Q1-2026); EV ~$2.85–3.80B at 2025 prices.
  • AZI price CSV (azitrading.com, accessed 2026-07-10) — 5-year daily OHLCV, split/dividend-adjusted, EMAs, beta; all-time high $17.14 (2021-02-18), all-time low $1.63 (2022-12-27), 52-week high $13.64 (2025-10-06), 52-week low $4.68 (2026-06-29), last $4.73 (2026-07-10).
  • AZI fundamentals valuation_index (accessed 2026-07-10) — own-history percentiles: P/B 1.79× (32nd pctile), P/S ~1,889× (noise, near-zero revenue), P/E null; book value/share $2.71.
  • FactorsToday (factorstoday.com, accessed 2026-07-10) — factor loadings (Market +1.82; “Space & Quantum Innovators” +0.75; Liquidity −2.25; LowVol −0.95; zero style-factor survival), leaderboard (y5 return −13.4%, vol 84.6%, max drawdown −84.0%; beta 2.49; alpha −0.49; rs_peak −72.4%), related stocks (RKLB 0.95, JOBY 0.95, AUR, NNE, AMPX), idiosyncratic vol ~50% annual.

Industry / third-party (qualitative)

  • eVTOL certification trackers and trade press: Aviation Week, Vertical Magazine, eVTOL.travel, eVTOL.news, lowaltitudeeconomy.aero, Aircraft Insider, Aerotime — Archer vs Joby cert status; Lilium/Volocopter insolvencies; EHang/AutoFlight China certifications; eIPP participation.
  • General financial media: CNBC, Forbes, Business Standard, FlyingMag, Manufacturing Dive, MacroTrends — SPAC deal, United order, Stellantis, Anduril, Palantir, Abu Dhabi, LA28, InterGlobe/Soracle/Korean Air/Ethiopian deals, ARK selling.
  • Federal Register / White House — June-2025 eVTOL executive order (“Unleashing American Drone Dominance”); FAA eIPP (September 2025).

Industry context (public)

  • Public eVTOL/AAM industry commentary and supplier presentations (e.g., Honeywell’s Advanced Air Mobility unit) referencing Archer, Vertical, and Electra as customers — used as value-chain framing; treat dated material as framework, not current data.

Notes on authority / reconciliation

  • ROIC.ai, AZI, and FactorsToday are third-party aggregated/statistical sources, not primary; for US-filer facts, EDGAR and the 10-K/10-Q govern. Management commentary (transcript, IR) is treated as hypothesis and validated against filings and external evidence. No analyst/aggregator figure was adopted as a price target (none is set outside the labeled Claude’s Take).